Royal Bank Of Canada Abb Vie Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Abb Vie Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 8,865,296 shares of ABBV stock, worth $1.6 Billion. This represents 0.37% of its overall portfolio holdings.

Number of Shares

8,865,296

Previous 8,626,699 2.77%

Holding current value

$1.6 Billion

Previous $1.48 Billion 18.32%

% of portfolio

0.37%

Previous 0.35%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $39.1 Million - $47.6 Million	238,597 Added 2.77%	8,865,296 $1.75 Billion
Q2 2024 Nov 06, 2024	SELL	$154.79 - $180.76 $24.4 Million - $28.5 Million	-157,417 Reduced 1.79%	8,626,699 $1.48 Billion
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $74 Million - $86.4 Million	477,799 Added 5.75%	8,784,116 $1.51 Billion
Q1 2024 Nov 05, 2024	SELL	$159.82 - $182.1 $104 Million - $118 Million	-649,056 Reduced 7.39%	8,135,060 $1.48 Billion
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $73 Million - $83.2 Million	-456,737 Reduced 5.21%	8,306,317 $1.51 Billion
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $67 Million - $75.4 Million	-486,564 Reduced 5.26%	8,763,054 $1.36 Billion
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $12.3 Million - $14.3 Million	92,234 Added 1.01%	9,249,618 $1.38 Billion
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $73.3 Million - $91.3 Million	-553,429 Reduced 5.7%	9,157,384 $1.23 Billion
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $9.45 Million - $10.9 Million	-65,354 Reduced 0.67%	9,710,813 $1.55 Billion
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $90.6 Million - $109 Million	655,096 Added 7.18%	9,776,167 $1.58 Billion
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $51.5 Million - $59 Million	-383,387 Reduced 4.03%	9,121,071 $1.22 Billion
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $39.7 Million - $50.4 Million	288,151 Added 3.13%	9,504,458 $1.46 Billion
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $157 Million - $195 Million	-1,190,762 Reduced 11.44%	9,216,307 $1.49 Billion
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $46 Million - $58.2 Million	428,451 Added 4.29%	10,407,069 $1.41 Billion
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $4.74 Million - $5.38 Million	44,549 Added 0.45%	9,978,618 $1.08 Billion
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1.05 Billion - $1.16 Billion	9,934,069 New	9,934,069 $1.12 Billion

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Abb Vie Inc. Transaction History